03% ointment has earned first-line, treatment-of-choice status in atopic blepharoconjunctivitis, the most common ocular complication of atopic dermatitis, Dr.
Twenty-two percent of patients on pimecrolimus cream for atopic blepharoconjunctivitis discontinued the topical calcineurin inhibitor because of insufficient efficacy, compared with 1.
For management of mild or suspected cases of bacterial conjunctivitis or blepharoconjunctivitis
, diamidine treatment is appropriate as an initial measure.
1 percent of subjects treated with ISV-502 met the clinical criteria necessary to demonstrate a resolution of the inflammatory signs and symptoms of blepharoconjunctivitis.
Blepharoconjunctivitis can be a chronic condition that is difficult to treat.
Initiated pivotal Phase 3 clinical trials to evaluate AzaSite Plus for the treatment of blepharoconjunctivitis
, a frequently chronic inflammation of the conjunctiva and eye lids caused by infections or allergic reactions - December 20, 2007
InSite Vision (AMEX:ISV) announced today that it has initiated pivotal Phase 3 clinical trials to evaluate AzaSite Plus[TM] for the treatment of blepharoconjunctivitis, a frequently-chronic inflammation of the conjunctiva and eye lids caused by infections or allergic reactions.
There are three treatment arms with the objective that AzaSite Plus will show superiority in treating blepharoconjunctivitis over AzaSite[R] (azithromycin ophthalmic solution) 1% - InSite's topical anti-infective drug on the market to treat bacterial conjunctivitis (pink eye) - and superiority over dexamethasone.